Alimentiv History
1986
Robarts Clinical Trials established by Dr. Henry Barnett
1997
Dr. Brian Feagan assumes leadership – GI Clinical Research Focus
2007
Implementation of central reading for endoscopy & CIMS®
Launch “Blue Box”
2011
Amsterdam and San Diego expansion
2012
Additional Europe expansion
2014
Independent ownership
2015
Launch histopathology & MRE modalities, and precision medicine services
2018
Ownership transition to Health Trust
2020
Robarts Clinical Trials is rebranded to Alimentiv
2021
Acquired McDougall Scientific (Alimentiv Statistics)
Toronto office opening
Launch of AcelaBio Histopathology Lab
2022-2023
New imaging solutions: Notō and Lucidity™
New imaging modalities: MRE/MRI and IUS
2024
Australia expansion
2025
AI partnerships: DovaVision™, PathwaysGI, IAG
LATAM expansion
2026
Alimentiv brand evolution
GI Is Our Why
Our purpose is to transform the lives of people living with gastrointestinal disorders. This is why we exist. It’s what drives every one of us every day — whether we’re advancing a new trial to life, supporting our sponsors, or solving challenges behind the scenes.
More Than a CRO
Our roots in academic GI research support everything we do. Through decades of collaboration with experts in academia and industry, we’re able to combine scientific depth and operational excellence with hands-on delivery and personalized services — creating standardized central reading, validated endpoints, and imaging innovations now widely used across global GI trials.
We continue to pioneer innovative research methodologies, validated endpoints, and trial designs that raise the standard for GI clinical development.
Mission:
We bring that purpose to life through pioneering GI research and innovative clinical trial development. We’re not just managing trials; we’re advancing science. With deep GI expertise, relentless curiosity, and a commitment to advancing gastrointestinal science, we shape and deliver solutions that make a real impact for patients.
Our Logo:
Our logo, symbolized by an enduring olive tree, profoundly links to our commitment to a 100-year view. Just like the olive tree, which has persisted through the cultivation of seeds over two millennia, our organization stands resilient in our commitment to advancing GI research and improving patient care.
Alimentiv’s Global Reach
Our site network is global, helping you activate sites with the right patients, experience, and infrastructure.
With worldwide reach and capabilities, we connect you to investigators, key opinion leaders (KOLs), and patient organizations that further optimize your research.
Our Partnerships
Progress in GI research is the result of collective work. We partner with academic centers, imaging societies (e.g., IBUS), patient advocacy groups such as the Crohn’s & Colitis Foundation, EUREOS, and Beyond Celiac community to help shape the future of GI care.
Key Collaborations
- STAR: An ongoing collaboration with a consortium focused on transforming the treatment of Crohn’s disease strictures and developing diagnostic tools
- IBUS: The International Bowel Ultrasound Group, a leader in advancing the use of intestinal ultrasound (IUS) in IBD clinical trials and in developing methods to quantify its value in disease assessment and outcomes monitoring
- EUREOS: A European consortium of healthcare professionals dedicated to improving the care of patients with Eosinophilic Esophagitis (EoE) through promoting research, harmonization of clinical practices, and awareness
- Beyond Celiac: A leading patient advocacy organization focused on accelerating research for a cure, raising awareness, and driving earlier diagnosis and treatment for those living with celiac disease
Key Affiliations
- Clinical Data Interchange Standards Consortium (CDISC): Develops data standards that improve medical research; Alimentiv is a Platinum Member, Registered Solutions Provider, and serves on the Industry Advisory Board
- The Applied Biostatistics Association (TABA): A professional group of applied biostatisticians and pharmaceutical researchers that has conducted seminars for 25+ years to support development and idea-sharing
- Statistical Society of Canada (SSC): Its mission is to encourage the development and use of statistics and probability
- American Statistical Association (ASA): The world’s largest community of statisticians, founded in 1839, supporting excellence through meetings, publications, education, accreditation, and advocacy
Learn More About Alimentiv
Explore the pillars that define our organization:
- Meet the executives, scientists, and fellows leading the future of GI research
Our Experts - Understand the rigorous Quality Management System (QMS) that safeguards your data
Explore Quality - Stay up to date with our latest announcements and conference appearances
News & Press
Our Commitment to Environmental, Social, and Governance (ESG)
From setting science-based climate targets to fostering a fair, growth-oriented workplace, we build better trials responsibly.
Alimentiv Health Trust is the parent company of Alimentiv, Inc. The mandate of the Trust is to invest in and build enduring companies and research that will transform human health. The Trust beneficiaries are the employees of the companies it holds.
AcelaBio (US) Inc. is a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for clinical/translational research and global clinical trials. It is wholly owned by the Alimentiv Health Trust and was created to meet the growing clinical research demand for quality and efficiency in laboratory service.